Kevin Charles Gorman, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 5,414 shares at $110.08 ($596K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Seasonal sale ($596k) by Chief Executive Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.08 | 2,707 | $298K | 50.0% |
| 2 | $110.08 | 2,707 | $298K | 50.0% |
| Total | $110.08 avg | 5,414 | $596K | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |